Portland, OR -- (SBWIRE) -- 07/07/2017 -- Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013.

"Early buyers will receive 20% customization on this report."

Commercialization of non-invasive cancer diagnosis is possible due to completion of Human Genome Project (HGP) that gives enormous diagnostic information based on genomic and proteomic. Increase in stringent regulatory guidelines and cost associated with diagnostics is hindering the growth of non-invasive cancer diagnostic market. The Ovarian Cancer National Alliance regulations for monitoring non-invasive diagnostics are issued by FDA, Medicare and Medicaid Services (CMS) and Social Security Administration (SSA).

Get full summary of the Report : https://www.alliedmarketresearch.com/noninvasive-cancer-diagnostics-market

Key companies included in report are Precision Therapeutics, A&G Pharmaceutical, Affymetrix Inc., AVIVA Biosciences Corporation, BIOVIEW Inc., Laboratory Corporation of America Holdings (LabCorp), , Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation, Gen-Probe Incorporated.

Request Sample Report : https://www.alliedmarketresearch.com/request-toc-and-sample/70

KEY MARKET SEGMENTS

GLOBAL MARKET, BY THERAPEUTICS

-Solid tumors
-Blood cancer
-Lung Cancer
-Breast Cancer
-Others

GLOBAL MARKET, BY TECHNIQUES

-Clinical Chemistry
-Immunochemistry/Immunoassay
-Molecular Diagnostics
-Other Clinical Instruments

GLOBAL MARKET, BY GEOGRAPHY

-North America
-Europe
-Asia-Pacific
-RoW

KEY AUDIENCES

-Medical devices manufacturing companies
-Pharmaceutical companies
-Government and Private Research Institutes
-Academic Institutes